DK110190A - Alveolaere surfaktantproteiner - Google Patents

Alveolaere surfaktantproteiner Download PDF

Info

Publication number
DK110190A
DK110190A DK110190A DK110190A DK110190A DK 110190 A DK110190 A DK 110190A DK 110190 A DK110190 A DK 110190A DK 110190 A DK110190 A DK 110190A DK 110190 A DK110190 A DK 110190A
Authority
DK
Denmark
Prior art keywords
alveolary
surfactant proteins
human
peptides
surfactant
Prior art date
Application number
DK110190A
Other languages
English (en)
Other versions
DK175843B1 (da
DK110190D0 (da
Inventor
Bradley J Benson
Robert T White
Jr James W Schilling
Douglas Buckley
Robert M Scarborough
Barbara Cordell
Original Assignee
California Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by California Biotechnology Inc filed Critical California Biotechnology Inc
Publication of DK110190D0 publication Critical patent/DK110190D0/da
Publication of DK110190A publication Critical patent/DK110190A/da
Application granted granted Critical
Publication of DK175843B1 publication Critical patent/DK175843B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Seasonings (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK199001101A 1987-11-04 1990-05-03 Polypeptider af overfladeaktive alvelolarproteiner (ASP), farmaceutisk sammensætning indeholdende polypeptidet, DNA-ekspressionssystem der koder for polypeptidet, samt fremgangsmåde til fremstilling af polypeptider med ASP-aktivitet DK175843B1 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11709987A 1987-11-04 1987-11-04
US26644388A 1988-11-01 1988-11-01
PCT/US1988/003899 WO1989004326A1 (en) 1987-11-04 1988-11-02 Alveolar surfactant proteins

Publications (3)

Publication Number Publication Date
DK110190D0 DK110190D0 (da) 1990-05-03
DK110190A true DK110190A (da) 1990-07-04
DK175843B1 DK175843B1 (da) 2005-03-29

Family

ID=26814915

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199001101A DK175843B1 (da) 1987-11-04 1990-05-03 Polypeptider af overfladeaktive alvelolarproteiner (ASP), farmaceutisk sammensætning indeholdende polypeptidet, DNA-ekspressionssystem der koder for polypeptidet, samt fremgangsmåde til fremstilling af polypeptider med ASP-aktivitet

Country Status (9)

Country Link
EP (1) EP0383837B1 (da)
JP (1) JP2602968B2 (da)
KR (2) KR960010558B1 (da)
AT (1) ATE163013T1 (da)
AU (1) AU625394B2 (da)
CA (1) CA1340461C (da)
DK (1) DK175843B1 (da)
IL (1) IL88293A0 (da)
WO (1) WO1989004326A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5104853A (en) * 1984-12-11 1992-04-14 California Biotechnology Inc. Alveolar surfactant proteins having cys to ser mutations
US5164369A (en) * 1988-01-06 1992-11-17 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
WO1990001540A1 (en) * 1988-08-11 1990-02-22 California Biotechnology Inc. Method for stabilizing heterologous protein expression and vectors for use therein
CA2063273C (en) * 1989-07-11 2002-09-24 Bradley J. Benson Surfactant compositions and methods
US5258496A (en) * 1990-07-10 1993-11-02 Scios Nova Inc. Isolation and purification of lung surfactant protein
US5272252A (en) * 1991-11-04 1993-12-21 Merrell Dow Pharmaceuticals Inc. Synthetic lung surfactant having antioxidant properties
KR100342806B1 (ko) * 1993-12-08 2002-11-29 미쯔비시 도꾜 세이야꾸 가부시끼가이샤 신규합성펩티드,이를함유하는폐표면활성제및호흡장애증후군치료제
DE4418936A1 (de) * 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
EP1101118B1 (en) 1998-07-24 2005-04-06 ALTANA Pharma AG Immunological determination of the hydrophobic pulmonary surfactant protein SP-C
ES2278609T3 (es) 1999-06-17 2007-08-16 Altana Pharma Ag Esteres tensioactivos de la proteina c.
WO2001019392A1 (en) 1999-09-16 2001-03-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
AU2002338882B2 (en) 2001-10-11 2008-04-03 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. Novel use of pulmonary surfactant
AU2002357168A1 (en) 2001-12-12 2003-07-09 Penn State Research Foundation Surfactant prevention of lung complications from cancer chemotherapy
US8236750B2 (en) 2004-08-06 2012-08-07 Nycomed Gmbh Composition comprising a pulmonary surfactant and a TNF-derived peptide
US7582312B2 (en) 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
PL1841458T3 (pl) 2005-01-06 2012-05-31 Discovery Lab Inc Schemat stosowania środka powierzchniowo czynnego do leczenia lub zapobiegania dysplazji oskrzelowo-płucnej
CA2663795A1 (en) 2006-09-19 2008-03-27 Discovery Laboratories, Inc. Pulmonary surfactant formulations and methods for promoting mucus clearance
US7951781B2 (en) 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides
JP5627581B2 (ja) 2008-06-25 2014-11-19 ブラーシュ・バイオテック・エルエルシー ソマトスタチン免疫原性増進のための組成物および方法
AU2008358353B2 (en) * 2008-06-25 2013-11-07 Braasch Biotech Llc Chloramphenicol acetyl transferase (CAT)-defective somatostatin fusion protein and uses thereof
AU2009324637B2 (en) 2008-12-10 2016-09-08 Paka Pulmonary Pharmaceuticals, Inc. Methods and compositions for delivery of medicaments to the lungs
WO2013188016A2 (en) 2012-05-04 2013-12-19 Discovery Laboratories, Inc. Surfactant therapy for exposure to ionizing radiation
WO2016029013A2 (en) 2014-08-21 2016-02-25 Braasch Biotech Llc Methods for improving immunological response in vaccinated animals
DE102016125491A1 (de) 2016-12-22 2018-06-28 Bombardier Transportation Gmbh Zugverband mit mindestens einer Aufhängungsvorrichtung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56026B1 (en) * 1982-10-19 1991-03-27 Cetus Corp Cysteine-depleted muteins of biologically active proteins
WO1988003170A1 (en) * 1986-10-24 1988-05-05 Whitsett Jeffrey A Pulmonary hydrophobic surfactant-associated proteins

Also Published As

Publication number Publication date
IL88293A0 (en) 1989-06-30
JPH03502095A (ja) 1991-05-16
KR900700505A (ko) 1990-08-13
AU625394B2 (en) 1992-07-09
KR960010558B1 (ko) 1996-08-02
EP0383837A1 (en) 1990-08-29
EP0383837B1 (en) 1998-02-04
WO1989004326A1 (en) 1989-05-18
DK175843B1 (da) 2005-03-29
CA1340461C (en) 1999-03-23
AU2797989A (en) 1989-06-01
EP0383837A4 (en) 1991-09-11
DK110190D0 (da) 1990-05-03
ATE163013T1 (de) 1998-02-15
JP2602968B2 (ja) 1997-04-23

Similar Documents

Publication Publication Date Title
DK110190A (da) Alveolaere surfaktantproteiner
ATE140963T1 (de) Verfahren zur herstellung von sekretierten rezeptoranalogen
NO831317L (no) Fremgangsmaate for fremstilling av funksjonelle menneske-urokinase proteiner.
ATE122357T1 (de) Polypeptide mit hormonwachstumsbefreiender wirkung.
ATE113607T1 (de) Polypeptidverbindungen mit wachstumshormonfreisetzender aktivität.
KR870700019A (ko) 재조합 폐포 계면활성 단백질
DE69933216D1 (de) Erythropoietin-analog-menschliches serum-albumin fusionsprotein
NL300062I2 (nl) Osteogene middelen.
DE3885459D1 (de) Molkeproteinfraktionen.
DE3750342D1 (de) Menschliches gamma-interferon-spezifisches Rezeptorprotein, Antikörper gegen dieses Protein, Verfahren zur Herstellung dieses Proteins und dieses Antikörpers und dieses Protein und diesen Antikörper enthaltende Zusammensetzungen.
PT87688A (pt) Hybrid protein c and method for its preparation
CA2083177A1 (en) Alveolar surfactant proteins
DK275788D0 (da) Protein
ES2080047T3 (es) Peptidos hiv y metodos para la deteccion de hiv.
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
DE69015372D1 (de) Protein-testverfahren.
ES2056872T3 (es) Proteina pp4-x anticoagulante, su preparacion y empleo.
NO891926L (no) Fremgangsmaate for fremstilling av stabile protein- eller peptidpreparater.
NO881942L (no) Fremgangsmaate for fremstilling av fremmede proteiner i streptomyceten.
NO874320D0 (no) Fremgangsmaate for bestemmelse av funksjonelle nivaaer av protein c i humant plasma.
SE8702724D0 (sv) Proteins and protein compositions and their use
SE8800010D0 (sv) Proteins and protein compositions and their use
LV10393A (lv) Savietojams cilveka olbaltumvielas preparats
NO173340C (no) Humant protein C antistoff
ATE96618T1 (de) Molkeproteinfraktionen.

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK